ResMed (RMD) PT Raised to $267 at KeyBanc Following Last Week's NDR

August 31, 2026 7:46 AM

(Updated - August 31, 2026 8:45 AM EDT)

KeyBanc analyst Brett Fishbin raised the price target on ResMed (NYSE ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

StreetInsider

Log in to your account:

ResMed (RMD) PT Raised to $267 at KeyBanc Following Last Week's NDR

Categories